JP2021512898A5 - - Google Patents
Info
- Publication number
- JP2021512898A5 JP2021512898A5 JP2020542580A JP2020542580A JP2021512898A5 JP 2021512898 A5 JP2021512898 A5 JP 2021512898A5 JP 2020542580 A JP2020542580 A JP 2020542580A JP 2020542580 A JP2020542580 A JP 2020542580A JP 2021512898 A5 JP2021512898 A5 JP 2021512898A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- alkyl
- salt according
- formula
- group
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862628699P | 2018-02-09 | 2018-02-09 | |
| US62/628,699 | 2018-02-09 | ||
| PCT/US2019/017422 WO2019157417A1 (en) | 2018-02-09 | 2019-02-11 | Heterocyclic p2y14 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021512898A JP2021512898A (ja) | 2021-05-20 |
| JPWO2019157417A5 JPWO2019157417A5 (https=) | 2022-02-24 |
| JP2021512898A5 true JP2021512898A5 (https=) | 2022-02-24 |
Family
ID=65529813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542580A Pending JP2021512898A (ja) | 2018-02-09 | 2019-02-11 | 複素環ｐ２ｙ１４受容体拮抗薬 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11584736B2 (https=) |
| EP (1) | EP3749651A1 (https=) |
| JP (1) | JP2021512898A (https=) |
| CN (1) | CN111868036A (https=) |
| AU (1) | AU2019218256A1 (https=) |
| CA (1) | CA3090788A1 (https=) |
| WO (1) | WO2019157417A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11708346B2 (en) | 2019-07-23 | 2023-07-25 | Saint Louis University | Treatment and prevention of neuropathic pain with P2Y14 antagonists |
| WO2022155037A1 (en) * | 2021-01-18 | 2022-07-21 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Heterocyclic p2y 14 receptor antagonists |
| CN116444482B (zh) * | 2023-06-14 | 2023-09-22 | 中国药科大学 | 噻吩-2-羧酸衍生物、其制备方法及医药用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4377586A (en) | 1981-04-30 | 1983-03-22 | The Upjohn Company | Diuretic 2,6-diaryl-4-pyridine carboxylic acids |
| GB0507200D0 (en) | 2005-04-08 | 2005-05-18 | Smithkline Beecham Corp | Chemical compounds |
| CA2706632A1 (en) * | 2007-12-04 | 2009-06-11 | Merck Frosst Canada Ltd. | Substituted 2-naphthoic acids as antagonists of gpr105 activity |
| US8580961B2 (en) | 2010-12-13 | 2013-11-12 | National Tsing Hua University | 2-phenyl-6-azolylpyridine-based ligand and group VIII transition metal complex |
| US9290453B2 (en) | 2010-12-23 | 2016-03-22 | Merck Sharp & Dohme Corp. | Quinolines and aza-quinolines as CRTH2 receptor modulators |
| DE112011105485T5 (de) | 2011-08-01 | 2014-06-12 | Mitsubishi Electric Corporation | Steuervorrichtung und Steuerverfahren für eine Spritzgussmaschine |
| EP2774919A1 (en) | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Novel sulfonamide TRPA1 receptor antagonists |
| PE20181366A1 (es) * | 2015-08-03 | 2018-08-27 | Bristol Myers Squibb Co | Compuestos heterociclicos utiles como moduladores de factor de necrosis tumoral (tnf) alfa |
| US10683277B2 (en) | 2015-09-25 | 2020-06-16 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Triazole derivatives as P2Y14 receptor antagonists |
| US11008340B2 (en) | 2015-11-20 | 2021-05-18 | Vitae Pharmaceuticals, Llc | Modulators of ROR-gamma |
| US11938114B2 (en) | 2017-03-10 | 2024-03-26 | Rutgers, The State University Of New Jersey | Bacterial efflux pump inhibitors |
| CN109096177A (zh) | 2018-08-31 | 2018-12-28 | 中国药科大学 | 3－酰胺基苯甲酸衍生物、其制备方法及医药用途 |
-
2019
- 2019-02-11 JP JP2020542580A patent/JP2021512898A/ja active Pending
- 2019-02-11 CN CN201980012696.0A patent/CN111868036A/zh active Pending
- 2019-02-11 EP EP19707559.1A patent/EP3749651A1/en active Pending
- 2019-02-11 CA CA3090788A patent/CA3090788A1/en active Pending
- 2019-02-11 US US16/967,177 patent/US11584736B2/en active Active
- 2019-02-11 WO PCT/US2019/017422 patent/WO2019157417A1/en not_active Ceased
- 2019-02-11 AU AU2019218256A patent/AU2019218256A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020123827A5 (https=) | ||
| FI4129989T3 (fi) | Dipeptidyylipeptidaasi 1:n estäjänä toimiva nitriilijohdannainen ja sen käyttö | |
| JP2021512898A5 (https=) | ||
| JP2006151984A5 (https=) | ||
| JPH08510479A (ja) | 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物 | |
| JP2010540508A5 (https=) | ||
| JPWO2023099592A5 (https=) | ||
| JP2007502804A5 (https=) | ||
| JP2010540525A5 (https=) | ||
| JP2009523841A5 (https=) | ||
| JP2012522759A5 (https=) | ||
| RU2007121219A (ru) | Диазациклоалканы как агонисты окситоцина | |
| JP2007522162A5 (https=) | ||
| CA2547347A1 (en) | Diazaindole-dicarbonyl-piperazinyl antiviral agents | |
| RU2006124856A (ru) | Гидронопольные производные в качестве агонистов по отношению к orl1 рецепторам человека | |
| RU2010116293A (ru) | Алкилтиопиримидины в качестве антагонистов crth2 | |
| JP2024540030A (ja) | 修飾インドール化合物 | |
| JP2008531585A5 (https=) | ||
| JP3131693B2 (ja) | 眼疾患を処置するための５―メチル―イソオキサゾール―４―カルボン酸アニリド類または２―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物 | |
| RU2019128534A (ru) | Химические соединения для лечения туберкулеза | |
| JP2006512321A5 (https=) | ||
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| JPWO2023201044A5 (https=) | ||
| JP2004533986A5 (https=) | ||
| JP2008519783A5 (https=) |